CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
about
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingCD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cellsOntogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.Garp as a therapeutic target for modulation of T regulatory cell function.Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs.Regulatory T-cell heterogeneity and the cancer immune responseLAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients.Liquid biopsies in gastrointestinal malignancies: when is the big day?An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation.
P2860
Q26742012-836E319C-0ECC-416C-A78D-A958289EC53FQ36545192-486B5EAC-0BD3-490E-9FA4-DC44118C420DQ37046528-EDF4785E-1861-4933-893E-4CDDD0CB79BDQ38924980-0E786282-77DA-4080-9B4F-A92DB50F9549Q38985262-293EE92D-02E6-4253-9732-0231C6943019Q39046334-E1899C43-93AB-4861-82F5-6813B3AE7058Q41057184-90517DC5-7A00-4792-B841-9FCAB67441D9Q42102497-A7A0B356-9BA3-46CC-9456-4BADDE6B999BQ43184376-00ADA18A-80BC-4341-B391-F34D8355D6F9Q47372761-D79F19E3-426E-48A7-AAAB-C00CEBA6FFC2Q47602259-AE257B22-7653-4038-AF16-121441D47111Q47663181-91553A9C-F3AF-4728-85B2-840BE0DE341E
P2860
CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@ast
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@en
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@nl
type
label
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@ast
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@en
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@nl
prefLabel
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@ast
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@en
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@nl
P2093
P2860
P1433
P1476
CD4⁺ T cells expressing latenc ...... tients with colorectal cancer.
@en
P2093
Ching-Tai Huang
Hsin-Yi Lai
Jayashri Mahalingam
Jian-He Fang
Jy-Ming Chiang
Po-Jung Su
Yung-Chang Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0108554
P407
P50
P577
2014-09-30T00:00:00Z